Brief: Velan Capital Investment Management Lp Reports 10.2% Stake In Jasper Therapeutics Inc As Of Feb 16 - SEC Filing
Feb 27 (Reuters) - Jasper Therapeutics Inc JSPR.O :
* VELAN CAPITAL INVESTMENT MANAGEMENT LP REPORTS 10.2% STAKE
IN
JASPER THERAPEUTICS INC AS OF FEB 16 - SEC FILING
* VELAN CAPITAL INVESTMENT MANAGEMENT LP SAYS PURCHASES
JASPER
THERAPEUTICS SHARES BASED ON BELIEF THAT SHARES, WHEN PURCHASED,
WERE "UNDERVALUED"
Source text: [ID:http://bit.ly/3KEg0pt]
Further company coverage: JSPR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Jasper Therapeutics
See all newsBrief: Jasper Therapeutics Announces Commencement Of An Offer To Purchase Outstanding Warrants
Jasper Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Jasper Therapeutics Q2 loss per share beats estimates, raises $132 mln
Jasper Therapeutics, Inc. expected to post a loss of 35 cents a share - Earnings Preview
Jasper Therapeutics rises; co announces all-stock merger with Kira Pharma